Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Advertisement
Hooman Djaladat, MDUpper Tract Urothelial Carcinoma | March 28, 2024
Dr. Djaladat discusses how the presence of specific biomarkers, such as CK|V oncosomes and D|CK|V cells, correlate with RFS.
View More
Alison Jane Birtle, MD, MBBS, MRCP, FRCRUpper Tract Urothelial Carcinoma | March 15, 2024
Dr. Birtle describes the utility of carboplatin versus cisplatin in this regimen and discusses metastasis-free survival.
Alison Jane Birtle, MD, MBBS, MRCP, FRCRUpper Tract Urothelial Carcinoma | March 21, 2024
Dr. Birtle highlights the trial's findings regarding the long-term overall survival benefit of adjuvant chemotherapy.
Alison Jane Birtle, MD, MBBS, MRCP, FRCRUpper Tract Urothelial Carcinoma | March 15, 2024
The POUT trial investigated adjuvant chemo for improving disease-specific survival in patients with UTUC.
Emily MenendezUpper Tract Urothelial Carcinoma | March 11, 2024
Liquid biopsy can benefit patients with UTUC by detecting rare events at higher incidences compared to tissue-based samples.
Katy MarshallUpper Tract Urothelial Carcinoma | March 1, 2024
Patients in the POUT trial were randomized to either a platinum-based adjuvant chemotherapy arm or a surveillance arm.
Katy MarshallUpper Tract Urothelial Carcinoma | March 11, 2024
Researchers investigated the ability of variant histology to predict oncological outcomes.
Emily MenendezUpper Tract Urothelial Carcinoma | December 20, 2023
The system provides a seal of the upper urinary tract to prevent urine leakage and can prevent the spread of tumor cells.
Emily MenendezUpper Tract Urothelial Carcinoma | December 12, 2023
Use of an sFI may increase accuracy in predicting complications and prognosis, as well as improve decision-making.
Christopher Wallis, MD, PhD, FRCSCUpper Tract Urothelial Carcinoma | March 11, 2024
Drs. Faltas and Wallis delve into the genomics of UTUC, including the evolution of disease and FGFR inhibition potential.
Christopher Wallis, MD, PhD, FRCSCUpper Tract Urothelial Carcinoma | December 18, 2023
Drs. Murray and Wallis discuss optimal patient selection, size criteria, and surgical ablation and chemoablation together.
Emily MenendezUpper Tract Urothelial Carcinoma | December 12, 2023
The nomogram outperformed 2 conventional models in predictive accuracy and showed higher benefit in decision curve analysis.
Roger Li, MDUpper Tract Urothelial Carcinoma | March 11, 2024
Dr. Li details what his study results suggested about ctDNA’s prognostic implications for survival in patients with UTUC.
Katy MarshallUpper Tract Urothelial Carcinoma | November 14, 2023
The study compared ureteroscopic surgery with radical nephroureterectomy.
Katy MarshallUpper Tract Urothelial Carcinoma | March 11, 2024
Researchers used whole-genome sequencing and a 152-gene panel to study the DNA of patients with high-risk UTUC.
Katy MarshallUpper Tract Urothelial Carcinoma | March 11, 2024
Investigators performed IHC of 4 DNA mismatch repair gene-related proteins (MMRPs) on all UTUC specimens.
Emily MenendezUpper Tract Urothelial Carcinoma | October 13, 2023
In URS and RIRS, pulse shapes were significantly different, with Ho:YAG being used in long-pulse and TFL in short-pulse mode.
Emily MenendezUpper Tract Urothelial Carcinoma | September 22, 2023
The novel nomogram demonstrated perfect performance in discrimination ability and clinical net benefit.
Emily MenendezUpper Tract Urothelial Carcinoma | September 8, 2023
Older patients over 70 years of age need improved care and management of UTUC to improve their outcomes.
Emily MenendezUpper Tract Urothelial Carcinoma | August 18, 2023
Patients who had initiated AC 90 days after RNU were examined to determine a relation between treatment efficacy and timing.
Advertisement
Advertisement
Advertisement